FDA approves new injectable drug to treat schizophrenia

FDA approved Aristada (aripiprazole lauroxil) extended release 
injection to treat adults with schizophrenia. Aristada is 
administered by a health care professional every four to six weeks 
using an injection in the arm or buttocks.


"People Who experience mood swings, fear, voices and visions"